88 related articles for article (PubMed ID: 22349825)
1. Phenotypical analysis of atypical PKCs in vivo function display a compensatory system at mouse embryonic day 7.5.
Seidl S; Braun U; Roos N; Li S; Lüdtke TH; Kispert A; Leitges M
PLoS One; 2013; 8(5):e62756. PubMed ID: 23690951
[TBL] [Abstract][Full Text] [Related]
2. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP
Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells.
Tolue Ghasaban F; Maharati A; Akhlaghipour I; Moghbeli M
Cancer Cell Int; 2023 Apr; 23(1):80. PubMed ID: 37098542
[TBL] [Abstract][Full Text] [Related]
4. CircRNAs: Roles in regulating head and neck squamous cell carcinoma.
Han X; Tian R; Wang C; Li Y; Song X
Front Oncol; 2022; 12():1026073. PubMed ID: 36483049
[TBL] [Abstract][Full Text] [Related]
5. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiation impairs myofiber hypertrophic growth in a pediatric tumor model.
Paris ND; Kallenbach JG; Bachman JF; Blanc RS; Johnston CJ; Hernady E; Williams JP; Chakkalakal JV
Sci Rep; 2020 Nov; 10(1):19501. PubMed ID: 33177579
[TBL] [Abstract][Full Text] [Related]
7. Measuring the lactate-to-creatine ratio via
Li H; Cui Y; Li F; Shi W; Gao W; Wang X; Zeng Q
Cell Mol Biol Lett; 2018; 23():27. PubMed ID: 29946338
[TBL] [Abstract][Full Text] [Related]
8. A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome.
Jatoi A; Grudem ME; Dockter TJ; Block MS; Villasboas JC; Tan A; Deering E; Kasi PM; Mansfield AS; Botero JP; Okuno SH; Smith DR; Fields AP
Support Care Cancer; 2017 Mar; 25(3):833-838. PubMed ID: 27838777
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cδ promotes proliferation and induces malignant transformation in skeletal muscle.
Czifra G; Szöllősi A; Nagy Z; Boros M; Juhász I; Kiss A; Erdődi F; Szabó T; Kovács I; Török M; Kovács L; Blumberg PM; Bíró T
J Cell Mol Med; 2015 Feb; 19(2):396-407. PubMed ID: 25283340
[TBL] [Abstract][Full Text] [Related]
10. New insights into signalling-pathway alterations in rhabdomyosarcoma.
Zhu B; Davie JK
Br J Cancer; 2015 Jan; 112(2):227-31. PubMed ID: 25211658
[TBL] [Abstract][Full Text] [Related]
11. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
[TBL] [Abstract][Full Text] [Related]
12. Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma.
Kikuchi K; Hettmer S; Aslam MI; Michalek JE; Laub W; Wilky BA; Loeb DM; Rubin BP; Wagers AJ; Keller C
PLoS Genet; 2014 Jan; 10(1):e1004107. PubMed ID: 24453992
[TBL] [Abstract][Full Text] [Related]
13. Atypical protein kinase Cι as a human oncogene and therapeutic target.
Parker PJ; Justilien V; Riou P; Linch M; Fields AP
Biochem Pharmacol; 2014 Mar; 88(1):1-11. PubMed ID: 24231509
[TBL] [Abstract][Full Text] [Related]
14. ATF2 knockdown reinforces oxidative stress-induced apoptosis in TE7 cancer cells.
Walluscheck D; Poehlmann A; Hartig R; Lendeckel U; Schönfeld P; Hotz-Wagenblatt A; Reissig K; Bajbouj K; Roessner A; Schneider-Stock R
J Cell Mol Med; 2013 Aug; 17(8):976-88. PubMed ID: 23800081
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.
Hill KS; Erdogan E; Khoor A; Walsh MP; Leitges M; Murray NR; Fields AP
Oncogene; 2014 Apr; 33(16):2134-44. PubMed ID: 23604119
[TBL] [Abstract][Full Text] [Related]
16. PKC signaling in glioblastoma.
do Carmo A; Balça-Silva J; Matias D; Lopes MC
Cancer Biol Ther; 2013 Apr; 14(4):287-94. PubMed ID: 23358475
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma.
Kikuchi K; Soundararajan A; Zarzabal LA; Weems CR; Nelon LD; Hampton ST; Michalek JE; Rubin BP; Fields AP; Keller C
Oncogene; 2013 Jan; 32(3):286-95. PubMed ID: 22349825
[TBL] [Abstract][Full Text] [Related]
18. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
Regala RP; Davis RK; Kunz A; Khoor A; Leitges M; Fields AP
Cancer Res; 2009 Oct; 69(19):7603-11. PubMed ID: 19738040
[TBL] [Abstract][Full Text] [Related]
19. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
